Development of class I-directed lymphocytotoxic antibodies after liver transplantation.
Bryan
C F
CF
Baylor University Medical Center, Dallas, TX 75246.
Newman
J T
JT
Tillquist
R L
RL
Husberg
B
B
Klintmalm
G B
GB
Stone
M J
MJ
D000888:Antibodies, Anti-Idiotypic / Q000032:analysis*; D001402:B-Lymphocytes / Q000276:immunology; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D015395:Histocompatibility Antigens Class I / Q000276:immunology*; D000949:Histocompatibility Antigens Class II / Q000032:analysis; D006801:Humans; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D011947:Receptors, Antigen, B-Cell / Q000032:analysis; D013601:T-Lymphocytes / Q000276:immunology*
D000888:Antibodies, Anti-Idiotypic; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D011947:Receptors, Antigen, B-Cell